Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.

Radioiodine is a therapeutic option in Europe for Graves’ disease (GD) and toxic multinodular goiter (MNG).PurposeTo compare empiric and calculated 131I activities using 2013 EANM recommendations. To look for predictive factors of therapeutic response to an empiric activity of 131I. To assess clinic